Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole (Q77743592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

1 reference

1 reference

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

3

Harmatz JS

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

Greenblatt DJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

2

von Moltke LL

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Mertzanis P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Graf JA

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Durol AL

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Counihan M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Roth-Schechter B

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

661-671

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

The maturation of clinical pharmacology: recognizing the contributions of Dr. Louis Lasagna.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

In vitro approaches to predicting drug interactions in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Sensitivity to triazolam in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Sedative effects and impaired learning and recall after single oral doses of lorazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Analysis of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection: application to single-dose pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Oral azole drugs as systemic antifungal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

Pharmacokinetic drug-drug interaction study of delavirdine and indinavir in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990057-1

10.1016/S0009-9236(98)90057-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871431%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference